biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a1bd-01a-11d-a12q-09
biospecimen_aliquot__bcr_aliquot_uuid	f5ac1986-272b-48d2-9a73-4a550e38a997
biospecimen_aliquot__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108431885
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	6
biospecimen_aliquot__plate_id	a12q
biospecimen_aliquot__plate_row	b
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.95
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a1bd-01a-11d
biospecimen_analyte__bcr_analyte_uuid	4ad9ab2b-254c-489c-8409-abf90d5ed55a
biospecimen_analyte__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a1bd
biospecimen_diagnostic_slides__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	a2aff7ad-ed47-43e4-87fe-62882baeb8da
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a1bd
biospecimen_normal_control__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_normal_control__ncedna_dna_conc	0.707
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	29
biospecimen_portion__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_portion__bcr_portion_barcode	tcga-e2-a1bd-01a-11
biospecimen_portion__bcr_portion_uuid	65621e49-233a-4e29-822b-2452aadd0c7c
biospecimen_portion__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_portion__date_of_creation	2011-01-10
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a1bd-01a-11d
biospecimen_protocol__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_sample__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_sample__bcr_sample_uuid	1ddc4c86-029f-49b5-893c-a218240d3fa4
biospecimen_sample__days_to_collection	260
biospecimen_sample__initial_weight	100
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e2-a1bd.df746e32-ad2f-49cb-9aa6-4f8494c16b20.pdf
biospecimen_sample__pathology_report_uuid	df746e32-ad2f-49cb-9aa6-4f8494c16b20
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	139a9795-35ff-4c82-9530-fb103ea5ca8c
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a1bd-01a-21-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
biospecimen_slide__bcr_sample_barcode	tcga-e2-a1bd-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a1bd-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	240c5cd9-3dad-40fe-82a9-f81214203302
biospecimen_slide__image_file_name	tcga-e2-a1bd-01a-01-tsa.240c5cd9-3dad-40fe-82a9-f81214203302.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	15
biospecimen_slide__percent_tumor_cells	85
biospecimen_slide__percent_tumor_nuclei	90
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a1bd
biospecimen_tumor_sample__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
clinical_drug__bcr_drug_barcode	tcga-e2-a1bd-d19445
clinical_drug__bcr_drug_uuid	2534a6c5-8dd5-454d-8887-6098e2b7cbb1
clinical_drug__bcr_patient_barcode	tcga-e2-a1bd
clinical_drug__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
clinical_drug__form_completion_date	2011-12-9
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	170
clinical_drug__pharmaceutical_tx_total_dose_units	mg/day
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	1
clinical_follow_up__bcr_followup_barcode	tcga-e2-a1bd-f19439
clinical_follow_up__bcr_followup_uuid	bc31751c-7def-4ddf-a6d3-fd1e906bab71
clinical_follow_up__bcr_patient_barcode	tcga-e2-a1bd
clinical_follow_up__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-12-9
clinical_follow_up__last_contact_days_to	520
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	53
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a1bd
clinical_patient__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
clinical_patient__birth_days_to	-19627
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 5+3 = 8
clinical_patient__er_positivity_scale_other	allred score = 8
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-25
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.0
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	10-19%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	317
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	1
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1bd
clinical_patient__pr_positivity_define_method	allred score 5+3 = 8
clinical_patient__pr_positivity_scale_other	allred score = 8
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a1bd
clinical_radiation__bcr_patient_uuid	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec
clinical_radiation__bcr_radiation_barcode	tcga-e2-a1bd-r19442
clinical_radiation__bcr_radiation_uuid	9fc62023-6140-4514-b9de-74bcc48157a0
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-12-9
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	108
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	55
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6600
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1BD-01A-11D-A12Q-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1BD-01A-11D-A12Q-09.bed.meta
manually_curated__id	tcga-e2-a1bd-01a-11d-a12q-09
manually_curated__md5sum	c88eafa34d84526dea83bf8b692bf0e6
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	f5ac1986-272b-48d2-9a73-4a550e38a997
manually_curated__tumor_tag	brca
